Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2013 by SciPharm SàRL
Sponsor:
Information provided by (Responsible Party):
SciPharm SàRL
ClinicalTrials.gov Identifier:
NCT01416636
First received: August 12, 2011
Last updated: January 20, 2014
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: No date given